Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 15,550 followers.

RT @SmallGTPases: Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRAS G12C. https://t.co/ht…

30 Aug 2022

Reply Repost Favourite

Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRAS G12C. https://t.co/ht2MSUZgR7

30 Aug 2022

Reply Repost Favourite

New research: Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C: Special oncogenic mutations in the RAS proteins lead to the aberrant activation of RAS and its downstream signaling pathways.… https://t.

10 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.